Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Cancers
|
January 8, 2025
Osimertinib as Second- and ≥Third-Line Treatment in Advanced and Recurrence EGFR-Mutant NSCLC Patients Harboring Acquired T790M Mutation
Mu-Han Peng, Yen-Hsiang Huang, Kuo-Hsuan Hsu, et al.
Archives of Biochemistry and Biophysics
|
October 8, 2025
Lauryl gallate induces apoptosis via p38-MAPK phosphorylation and autophagy in chemoresistant human lung cancer cells
Yen-Hsiang Huang, Shur-Hueih Cherng, Ling-Yen Chiu, et al.
Therapeutic Advances in Medical Oncology
|
November 1, 2024
Real-world clinical efficacy of bevacizumab biosimilar in patients with advanced non-small-cell lung cancer
Wei-Fan Ou, Kuo-Hsuan Hsu, Jeng-Sen Tseng, et al.
Oncotargets and Therapy
|
July 1, 2025
Survival Outcomes in Lung Cancer Patients Newly Diagnosed Through Brain Metastasis Surgery: Impact of Druggable Mutations and Radiotherapy
Tzu-I Chuang, Kuo-Hsuan Hsu, Po-Hsin Lee, et al.
Scientific Reports
|
May 1, 2021
Higher CD4/CD8 ratio of pleural effusion predicts better survival for lung cancer patients receiving immune checkpoint inhibitors
Po-Hsin Lee, Tsung-Ying Yang, Kun-Chieh Chen, et al.
Journal of Clinical Medicine
|
January 8, 2023
Reactivation of Hepatitis B Virus in Lung Cancer Patients Receiving Tyrosine Kinase Inhibitor Treatment
Po-Hsin Lee, Yen-Hsiang Huang, Yu-Wei Hsu, et al.
Medicine
|
June 17, 2022
Characteristics and immune checkpoint inhibitor effects on non-smoking non-small cell lung cancer with KRAS mutation: A single center cohort (STROBE-compliant)
Jia-Jun Wu, Po-Hsin Lee, Zhe-Rong Zheng, et al.
Plos One
|
August 18, 2022
Various impacts of driver mutations on the PD-L1 expression of NSCLC
Cheng-Hsiang Chu, Yen-Hsiang Huang, Po-Hsin Lee, et al.
JCO Precision Oncology
|
September 30, 2024
Using a Polygenic Risk Score to Improve the Risk Prediction of Non-Small Cell Lung Cancer in Taiwan
Po-Hsin Lee, I-Chieh Chen, Yi-Ming Chen, et al.
Journal of Advanced Research
|
July 7, 2026
Study of benign prostatic hyperplasia and androgen pathway manipulation on lung cancer survivals
Po-Hsin Lee, Pang-Ting Cheng, Ayse Celik, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Cancers
|
January 8, 2025
Osimertinib as Second- and ≥Third-Line Treatment in Advanced and Recurrence EGFR-Mutant NSCLC Patients Harboring Acquired T790M Mutation
Mu-Han Peng, Yen-Hsiang Huang, Kuo-Hsuan Hsu, et al.
Archives of Biochemistry and Biophysics
|
October 8, 2025
Lauryl gallate induces apoptosis via p38-MAPK phosphorylation and autophagy in chemoresistant human lung cancer cells
Yen-Hsiang Huang, Shur-Hueih Cherng, Ling-Yen Chiu, et al.
Therapeutic Advances in Medical Oncology
|
November 1, 2024
Real-world clinical efficacy of bevacizumab biosimilar in patients with advanced non-small-cell lung cancer
Wei-Fan Ou, Kuo-Hsuan Hsu, Jeng-Sen Tseng, et al.
Oncotargets and Therapy
|
July 1, 2025
Survival Outcomes in Lung Cancer Patients Newly Diagnosed Through Brain Metastasis Surgery: Impact of Druggable Mutations and Radiotherapy
Tzu-I Chuang, Kuo-Hsuan Hsu, Po-Hsin Lee, et al.
Scientific Reports
|
May 1, 2021
Higher CD4/CD8 ratio of pleural effusion predicts better survival for lung cancer patients receiving immune checkpoint inhibitors
Po-Hsin Lee, Tsung-Ying Yang, Kun-Chieh Chen, et al.
Journal of Clinical Medicine
|
January 8, 2023
Reactivation of Hepatitis B Virus in Lung Cancer Patients Receiving Tyrosine Kinase Inhibitor Treatment
Po-Hsin Lee, Yen-Hsiang Huang, Yu-Wei Hsu, et al.
Medicine
|
June 17, 2022
Characteristics and immune checkpoint inhibitor effects on non-smoking non-small cell lung cancer with KRAS mutation: A single center cohort (STROBE-compliant)
Jia-Jun Wu, Po-Hsin Lee, Zhe-Rong Zheng, et al.
Plos One
|
August 18, 2022
Various impacts of driver mutations on the PD-L1 expression of NSCLC
Cheng-Hsiang Chu, Yen-Hsiang Huang, Po-Hsin Lee, et al.
JCO Precision Oncology
|
September 30, 2024
Using a Polygenic Risk Score to Improve the Risk Prediction of Non-Small Cell Lung Cancer in Taiwan
Po-Hsin Lee, I-Chieh Chen, Yi-Ming Chen, et al.
Journal of Advanced Research
|
July 7, 2026
Study of benign prostatic hyperplasia and androgen pathway manipulation on lung cancer survivals
Po-Hsin Lee, Pang-Ting Cheng, Ayse Celik, et al.
Page
of 3